Gardenia jasminoides inhibits tumor necrosis factor-alpha-induced vascular inflammation in endothelial cells

Phytotherapy Research : PTR
Sun Mi HwangHo Sub Lee

Abstract

Inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha) enhance binding of low-density lipoprotein to endothelium and upregulate the expression of endothelial leukocyte adhesion molecules during atherogenesis. The present study examined the effect of ethanol extract of Gardenia jasminoides (EGJ) on vascular inflammation in primary cultured human umbilical vein endothelial cells (HUVEC). TNF-alpha-induced the expression of vascular cell adhesion molecule-1 (VCAM-1) and endothelial cell-selectin (E-selectin) expression was inhibited in HUVEC pretreated with EGJ. In a functional study, EGJ dose-dependently attenuated adhesion of HL-60 monocytes to endothelial monolayers. A further analysis indicated that EGJ attenuated TNF-alpha-induced nuclear p65 nuclear factor-kappa B (NF-kappaB) translocation, suggesting that EGJ primarily affects the TNF-alpha-induced NF-kappaB signaling pathway. Taken together, we provided here the first evidence showing that EGJ is able to inhibit TNF-alpha-induced NF-kappaB activation, adhesion molecule expression, and monocyte-endothelial interaction, suggesting an anti-inflammatory role of EGJ, which may be useful in preventing vascular diseases, such as atherosclerosis.

References

May 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C K Sen, L Packer
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Jan 14, 1999·The New England Journal of Medicine·R Ross
Jun 22, 1999·The New England Journal of Medicine·G D Sloop
Jun 22, 1999·Coronary Artery Disease·E S Biegelsen, J Loscalzo
Jul 3, 1999·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·M FabbriR Pardi
Mar 17, 2000·Circulation Research·K K GriendlingM Ushio-Fukai
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Jan 3, 2001·The Journal of Clinical Investigation·P P Tak, G S Firestein
Feb 13, 2001·The Journal of Clinical Investigation·Y Yamamoto, R B Gaynor
Mar 21, 2003·The American Journal of Cardiology·David HarrisonHelmut Drexler
Oct 3, 2003·European Journal of Pharmacology·Ileana ManduteanuMaya Simionescu
Jan 13, 2004·Biochemical and Biophysical Research Communications·Yon Sik ChoiYoungmi Kim Pak
Jun 9, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·De-xiu BuZhong-qun Yan
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David Z QianRoberto Pili
Jul 11, 2006·European Journal of Pharmacology·Liang ShengLiang Xi
Nov 6, 2008·World Journal of Gastroenterology : WJG·Won-Seok JungHo-Joon Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.